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Assessment of Health Conditions and Health Service Use
Among Transgender Patients in Canada
Alex Abramovich, PhD; Claire de Oliveira, PhD; Tara Kiran, MD; Tomisin Iwajomo, MPH; Lori E. Ross, PhD; Paul Kurdyak, MD
Abstract
IMPORTANCE Transgender individuals experience stigma, discrimination, and socioeconomic
disadvantages, leading to a myriad of poor health outcomes and high rates of disease burden;
however, transgender health continues to be an understudied area.
OBJECTIVE To examine sociodemographic characteristics, health conditions, and health service
utilization patterns among transgender individuals compared with the general population.
DESIGN, SETTING, ANDPARTICIPANTS This cross-sectional study of 2085 transgender individuals
from 3 large cities in Ontario, Canada, compared characteristics and health service use among
transgender individuals with the general population in the province. Transgender individuals were
identified through data obtained from 4 outpatient community and hospital clinics, which were
linked with health administrative data between January 2012 and December 2016. Data were
analyzed between October 2018 andMay 2020. Individuals were age-matched 1:5 to a random 5%
sample of the general Ontario population (10 425 individuals).
MAINOUTCOMESANDMEASURES Sociodemographic variables, health service use, and chronic
conditions among transgender individuals and the general population were compared.
RESULTS This study included a sample of 2085 transgender individuals with a mean (SD) age of
30.40 (12.81) years; 771 (37.0%) identified as transgender women. Compared with 10 425 cisgender
controls, trangender individuals were more likely to live in lower-income neighborhoods (lowest-
income quintile: 625 [30.0%] vs 2197 [21.1%]; P < .001) and experience chronic physical andmental
health conditions, including higher rates of asthma (489 [23.5%] vs 2034 [19.5%]; P < .001),
diabetes (115 [5.5%] vs 352 [3.4%]; P < .001), chronic obstructive pulmonary disease (51 [2.4%] vs
156 [1.5%]; P < .001), and HIV (34 [1.6%] vs 12 [0.1%]; P < .001). Comorbid chronic health conditions
were higher among the transgender population compared with the cisgender population (702
[33.7%] vs 2941 [28.2%]; P < .001). Transgender individuals also had higher health service use
compared with the general population, particularly for mental health and self-harm, includingmean
(SD) number of psychiatrist visits between January 2012 and December 2016 (8.25 [23.13] vs 0.93
[9.57]; standardized difference, 5.84).
CONCLUSIONS ANDRELEVANCE This study found higher rates of mental and physical
comorbidities and higher health service use among transgender individuals comparedwith cisgender
individuals. Further research should explore reasons for these findings. Clinicians caring for
transgender individuals should be aware of the high potential for mental health issues and self-harm.
JAMA Network Open. 2020;3(8):e2015036. doi:10.1001/jamanetworkopen.2020.15036
Key Points
Question How do sociodemographic
characteristics, chronic conditions, and
health service utilization trajectories
differ among transgender individuals
compared with the general population?
Findings This cross-sectional study
identified and linked health
administrative data for 2085
transgender individuals in Ontario,
Canada, and found that transgender
individuals are more likely to live in
lower-income neighborhoods,
experience chronic health conditions,
and have higher health service use than
the general population.
Meaning This study demonstrates the
need to improve the capacity to identify
transgender individuals in
administrative health data to
understand the factors underlying their
high rates of disease burden.
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Introduction
Transgender is an umbrella term that refers to individuals who do not identify with the sex assigned
to them at birth (eg, a person who was assigned male at birth but identifies as a woman is a
transgender woman). Gender expansive refers to a wide range of gender identities and expressions
that expand and broaden the definitions of gender-normative identities and are neither male nor
female, whereas cisgender refers to individuals who identify as the sex assigned to them at birth (eg,
a person who was assigned female at birth and identifies as a woman is a cisgender woman).
Population studies yielding prevalence data for transgender individuals have estimated that 0.5% to
1.3% of adults are transgender and that there are approximately 25 million transgender individuals
worldwide.1 Research has consistently shown that transgender individuals aremedically underserved
and experience ongoing stigma, discrimination, and socioeconomic disadvantages, leading to a
myriad of poor health outcomes and high rates of disease burden.1-5However, general health
continues to be among the most understudied areas in transgender research.4Wemust be able to
identify and study transgender individuals at a population level to conduct rigorous and meaningful
analysis of the transgender population.
Hospital and primary health care settings routinely collect administrative data on sex
designation, rather than gender identity, based on what is listed on a person’s provincial health
insurance card.6 The expectation that every individual will identify with the gender binary creates
challenges for transgender and gender-expansive individuals to navigate the health care system and
perpetuates institutional erasure. The lack of data collection on gender identity has resulted in
limited information on the health conditions that affect the transgender population and how they are
being served by the health care system. Data are primarily available through self-reported
surveys,2,6-13making it difficult to understand the health care utilization patterns and health
outcomes among transgender individuals.
We sought to identify a sample of transgender individuals in administrative data and use the
sample to characterize the sociodemographic characteristics, health conditions, and health service
use of transgender individuals compared with the general population in 1 Canadian province. We
were specifically interested in the prevalence of asthma, cancer, and HIV, based on findings from
previous research4 that has reported a higher prevalence of these conditions among transgender
individuals. In addition, wewere interested inmental health service use, given that previous research
has reportedmental health issues among transgender individuals, resulting from stigma,
discrimination, and violence.1,4,5We hypothesized that transgender individuals would have higher
rates of mental illness and more emergency department (ED) visits and hospitalizations owing to
mental health and self-harm related reasons.
Methods
Setting and Context
Ontario is Canada’s most populated province, with approximately 14.5 million people counted in
2019. The Ontario Health Insurance Plan provides health insurance coverage for hospital and
physician visits andmedically necessary laboratory tests to all permanent residents. Access to
transgender-inclusive health care and transgender rights differ across Canada. The Ontario Human
Rights Code protects people from discrimination and harassment due to gender identity and gender
expression; however, transgender Ontarians report experiences of widespread discrimination in
health care settings.14
StudyDesign
We conducted a cross-sectional study comparing characteristics and service use of transgender
individuals with the general population in Ontario, Canada, between January 2012 and December
2016. All sociodemographic variables were calculated as of January 1, 2016; data were analyzed
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between October 2018 andMay 2020. We identified transgender individuals in community health
centers and an outpatient hospital clinic and linked their data with population-wide health
administrative data held at ICES. ICES is a prescribed entity under section 45 of Ontario’s Personal
Health Information Protection Act. Section 45 authorizes ICES to collect personal health information,
without consent, for the purpose of analysis or compiling statistical information, including the
management, evaluation, monitoring, and allocation of resources, for all or part of the health system.
Projects conducted under section 45 by definition do not require review by a research ethics board.
This project was conducted under section 45 and approved by ICES’s privacy and legal office. This
study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
reporting guideline.
Data Sources
The ICES data repository includes individual-level, linkable, longitudinal data onmost publicly funded
health care services for individuals covered by Ontario health insurance. These data sets were linked
using unique encoded identifiers and analyzed at ICES. The Ontario Health Insurance Plan claims
database includes data on outpatient care, namely claims for physician services. The Registered
Persons Database was used to capture sociodemographic variables and all-cause mortality (if death
occurred during the study period). The Immigration, Refugees, and Citizenship Canada Permanent
Resident Database was used to determine migrant status. The Ontario Drug Benefit Database was
used to determine whether individuals received benefits based on financial need. The National
Ambulatory Care Reporting Systemwas used to identify all ambulatory care, including ED visits. The
Ontario Mental Health Reporting Systemwas used to identify hospitalizations occurring in mental
health–designated hospital beds. The Discharge Abstract Database was used to identify non–mental
health hospital admissions. Medical comorbidities were determined by validated chronic condition
algorithms based on physician billings and hospital discharge databases available at ICES.15-20We
identified other psychiatric andmedical comorbidity using the Johns Hopkins Adjusted Clinical Group
software, version 10.0, which categorizes codes from the ninth and tenth revisions of the
International Classification of Diseases (ICD-9/ICD-10) and into diagnosis clusters referred to as
Aggregated Diagnosis Groups (ADGs), based on 5 clinical dimensions21 (described in eAppendix 1 in
the Supplement).
Identifying Transgender Individuals
Transgender individuals were identified through data obtained from 4 outpatient health clinics
across Ontario. Clinics were located in 3 cities (Ottawa, Thunder Bay, and Toronto) and have expertise
inworkingwith the transgender population. All 4 clinics regularly collect data on self-defined gender
identity, making it possible for them to identify their transgender patients within their clinic health
records. Data from each clinic were extracted through an electronic medical record search or manual
record audit to identify all transgender patients seen at each clinic between January 2012 and
December 2016. The following information was extracted from the clinic medical records for
transgender individuals: Ontario health insurance numbers, date of birth, sex listed on health card,
and self-defined gender identity. Data were linked to administrative databases held at ICES using
Ontario health insurance numbers and date of birth. One of the participating clinics was unable to
provide the gender identity information of transgender individuals. Cases in which gender identity
was missing were classified as unknown. Because of the small sample sizes in numerous gender
identity categories and to protect confidentiality and privacy, self-reported gender identities were
collapsed into the following 4 categories: transgender woman or transfeminine, transgender man or
transmasculine, nonbinary, and unknown. The full spectrum of gender identities represented in our
data can be found in eAppendix 2 in the Supplement.
JAMANetworkOpen | Public Health Health Conditions and Health Service Use Among Transgender Patients in Canada
JAMA Network Open. 2020;3(8):e2015036. doi:10.1001/jamanetworkopen.2020.15036 (Reprinted) August 28, 2020 3/12
Downloaded From: https://jamanetwork.com/ on 09/10/2020
Matched Controls
Transgender individuals were matched 1:5 on age to a random 5% sample of the general Ontario
population (excluding individuals included in the transgender sample). The comparison sample was
meant to only include cisgender individuals; however, there is a possibility that transgender
individuals who were not captured in the transgender sample may have been included, given that
approximately 0.5% to 1.3% of adults are transgender1 and wewere not able to identify all
transgender individuals in Ontario. The transgender and general population samples included
Ontario residents eligible for Ontario health insurance from 2012 to 2016.
Variables
Wemeasured the following sociodemographic variables for both groups: age, sex listed on health
card, neighborhood-level income (measured in quintiles at the census tract level), rurality (derived
through postal code), and migrant status (ie, Canadian born, immigrant, refugee). We assessed
whether individuals received prescriptions via the public drug plan (Ontario Drug Benefit), a marker
of low income. We measured the following medical comorbidities: rheumatoid arthritis, asthma,
cancer, chronic health failure, Crohn disease and colitis, chronic obstructive pulmonary disease
(COPD), diabetes, HIV, hypertension, andmyocardial infarction. Health service variables measured
included physician visits (defined as primary care physician visits and measured by total visits);
mental health and non-mental health visits and psychiatrist visits; and visits to other specialists such
as urologists, plastic surgeons, obstetrician-gynecologists, cardiologists, and endocrinologists. We
also measured ED visits by total number of visits, mental health–related ED visits, self-harm–related
ED visits, and non–mental health–related ED visits. We examined hospitalizations by total number of
hospitalizations, mental health–related hospitalizations, and non–mental health–related
hospitalizations.
Statistical Analysis
Descriptive and baseline characteristics (frequencies andmeans) were calculated across both
samples. Differences between both samples and between gender identity categories were explored
using χ2 tests, 1-way analysis of variance, and standardized mean differences (SMDs). P values and
standardized differences were used to test whether groups were statistically different from one
another, with significance set to P < .05 in 2-tailed tests. All analyses used SAS version 9.4 (SAS
Institute).
Results
The sociodemographic and clinical characteristics of 2085 transgender individuals included in the
study compared with a 5% random sample of 10 425 age-matched cisgender individuals are
presented in Table 1. Transgender individuals had amean (SD) age of 30 (12.87) years; most were
under the age of 45, with 882 (42.3%) aged 25 to 44 years and 894 (42.9%) younger than 24 years
(Table 1). Transgender individuals in the unknown gender identity category had the highest mean
(SD) age (32.06 [14.17] years), followed by transgender women (31.36 [13.08] years), transgender
men (28.95 [11.94] years), and nonbinary individuals (28.75 [11.29] years) (Table 2).
Transgender individuals were more likely to live in the 2 lowest neighborhood income quintiles
compared with matched controls (lowest-income quintile: 625 [30.0%] vs 2197 [21.1%]; P < .001).
Most transgender individuals resided in urban settings (1977 individuals [94.8%]), similar to the
general population (11 372 [90.1%]). There was a higher proportion of transgender individuals
covered under the public provincial drug plan compared with thematched controls (1103 [52.9%] vs
2427 [23.3%]; P < .001).
Transgender individuals had higher rates of asthma (489 [23.5%] vs 2034 [19.5%]; P < .001),
diabetes (115 [5.5%] vs 352 [3.4%]; P < .001), COPD (51 [2.4%] vs 156 [1.5%]; P = .002), and HIV (34
[1.6%] vs 12 [0.1%]; P < .001) comparedwith cisgender controls. Clinical chronic comorbidities were
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Table 1. Sociodemographic and Clinical Characteristics of Transgender Individuals ComparedWith Age-Matched Cisgender Individuals
Characteristics
No. (%)
P value SMD
Variance
ratio
Transgender individuals
(n = 2085)
Cisgender individuals
(n = 10 425)
Total
(N = 12 510)
Demographic characteristics
Age, y
Mean (SD) 30.25 (12.87) 30.25 (12.86) 30.25 (12.86)
NA NA NA
Median (IQR) 26 (21-37) 26 (21-37) 26 (21-37)
Age group, y
≤24 894 (42.9) 4470 (42.9) 5364 (42.9)
NA NA NA
25-44 882 (42.3) 4410 (42.3) 5292 (42.3)
45-64 276 (13.2) 1380 (13.2) 1656 (13.2)
≥65 33 (1.6) 165 (1.6) 198 (1.6)
Sex listed on health card
Female 1055 (50.6) 5197 (49.9) 6252 (50.0)
.53
0.01 0.20
Male 1030 (49.4) 5228 (50.1) 6258 (50.0) 0.01 0.20
Nearest census-based
neighborhood incomea
1 (low) 625 (30.0) 2197 (21.1) 2822 (22.6)
<.001
0.21 0.16
2 (medium-low) 417 (20.0) 2036 (19.5) 2453 (19.6) 0.01 0.20
3 (medium) 368 (17.6) 2093 (20.1) 2461 (19.7) 0.06 0.22
4 (medium-high) 297 (14.2) 1990 (19.1) 2287 (18.3) 0.13 0.25
5 (high) 340 (16.3) 2083 (20.0) 2423 (19.4) 0.10 0.23
Missing 38 (1.8) 26 (0.2) 64 (0.5) 0.16 0.03
Rural residence
Missing 6 (0.3) 26 (0.2) 32 (0.3)
<.001
0.01 0.17
No 1977 (94.8) 9395 (90.1) 11 372 (90.9) 0.18 0.36
Yes 102 (4.9) 1004 (9.6) 1106 (8.8) 0.18 0.37
Migrant status
Canadian born 1851 (88.8) 8653 (83.0) 10 504 (84.0)
<.001
0.17 0.28
Immigrant 188 (9.0) 1481 (14.2) 1669 (13.3) 0.16 0.30
Refugee 46 (2.2) 291 (2.8) 337 (2.7) 0.04 0.25
Clinical characteristics
Ontario drug benefit
coverageb
No 982 (47.1) 7998 (76.7) 8980 (71.8)
<.001
0.64 0.14
Yes 1103 (52.9) 2427 (23.3) 3530 (28.2) 0.64 0.14
Clinical comorbidities
Rheumatoid arthritis 6 (0.3) 46 (0.4) 52 (0.4) .32 0.03 0.31
Asthma 489 (23.5) 2034 (19.5) 2523 (20.2) <.001 0.10 0.17
Cancer 28 (1.3) 116 (1.1) 144 (1.2) .37 0.02 0.17
Chronic heart failure 8 (0.4) 22 (0.2) 30 (0.2) .14 0.03 0.11
Crohn disease or colitis 10 (0.5) 61 (0.6) 71 (0.6) .56 0.01 0.24
COPD 51 (2.4) 156 (1.5) 207 (1.7) .002 0.07 0.12
Diabetes 115 (5.5) 352 (3.4) 467 (3.7) <.001 0.10 0.13
HIV 34 (1.6) 12 (0.1) 46 (0.4) <.001 0.16 0.01
Hypertension 128 (6.1) 644 (6.2) 772 (6.2) .95 0 0.20
Myocardial infarction 6 (0.3) 28 (0.3) 34 (0.3) .88 0 0.19
Total comorbidity count
Mean (SD) 0.42 (0.67) 0.33 (0.60) 0.35 (0.61) <.001 0.14 1.26
Median (IQR) 0 (0-1) 0 (0-1) 0 (0-1) <.001 0.13 1.15
0 1383 (66.3) 7484 (71.8) 8867 (70.9)
<.001
0.12 0.18
1 565 (27.1) 2544 (24.4) 3109 (24.9) .06 0.19
≥2 137 (6.6) 397 (3.8) 534 (4.3) .12 0.12
(continued)
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higher among the transgender population compared with the general population (702 [33.7%] vs
2941 [28.2%]; P < .001). Transgender individuals also had a higher prevalence of comorbidity as
measured by ADGs, including a higher prevalence of bothmedical ADGs and psychosocial ADGs, the
latter reflecting a greater burden of psychiatric comorbidity. For example, psychiatric comorbidities
were reported in 2384 (22.9%) in the general population (P < .001) compared with 1591 transgender
individuals (76.3%).
Table 3 presents health service use among transgender and age-matched cisgender individuals.
Overall health service use was significantly higher among transgender individuals (eTable 1 in the
Supplement). Transgender individuals had a higher mean (SD) number of mental health–related
primary care physician visits (9.11 [20.19] vs 2.10 [13.44]; SMD, 2.26) and non–mental health–related
primary care physician visits (13.44 [14.66] vs 11.08 [13.19]; SMD, 1.24), psychiatrist visits (8.25 [23.13]
Table 1. Sociodemographic and Clinical Characteristics of Transgender Individuals ComparedWith Age-Matched Cisgender Individuals (continued)
Characteristics
No. (%)
P value SMD
Variance
ratio
Transgender individuals
(n = 2085)
Cisgender individuals
(n = 10 425)
Total
(N = 12 510)
Psychosocial ADGs
0, Absence 494 (23.7) 8041 (77.1) 8535 (68.2) <.001 1.26 0.20
ADG23, psychosocial: time
limited, minor
380 (18.2) 381 (3.7) 761 (6.1) <.001 0.48 0.05
ADG24, psychosocial: recurrent
or persistent, stable
1514 (72.6) 2127 (20.4) 3641 (29.1) <.001 1.23 0.16
ADG25, psychosocial: recurrent
or persistent, unstable
487 (23.4) 388 (3.7) 875 (7.0) <.001 0.60 0.04
Nonpsychosocial ADGs
0, Absence 1089 (52.2) 7457 (71.5) 8546 (68.3) <.001 0.41 0.16
ADG3, time limited: major 122 (5.9) 315 (3.0) 437 (3.5) <.001 0.14 0.11
ADG4, time limited: major
primary infections
221 (10.6) 694 (6.7) 915 (7.3) <.001 0.14 0.13
ADG9, likely to recur:
progressive
20 (1.0) 71 (0.7) 91 (0.7) .17 0.03 0.14
ADG11, chronic medical:
unstable
528 (25.3) 839 (8.0) 1367 (10.9) <.001 0.48 0.08
ADG16, chronic specialty:
unstable orthopedic
21 (1.0) 85 (0.8) 106 (0.8) .38 0.02 0.16
ADG22, injuries or adverse
effects: major
481 (23.1) 1504 (14.4) 1985 (15.9) <.001 0.22 0.14
ADG32, malignant neoplasms 67 (3.2) 287 (2.8) 354 (2.8) .25 0.03 0.17
Abbreviations: ADG, Aggregate Diagnosis Group; COPD, chronic obstructive pulmonary
disease; IQR, interquartile range; SMD, standardizedmean difference.
a Income quintiles (source: Census data from Statistics Canada) are derived from the
household after-tax income per single person equivalent (ie, a measure that takes into
account the economies of scale, so that a 2-person household counts as 1.24 single-
person equivalents). Income quintiles are also calculated within each census unit to
account for differences in cost of living, so that 2 individuals with the same incomewho
live in different metropolitan areas may be grouped in different quintiles.
b Based on whether an outpatient drug prescription was filled.
Table 2. Age Distribution of Transgender Individuals by Gender Identity Category
No. (%)
Nonbinary (n = 130)
Transgender
Unknown
(n = 346) Total (N = 2008)
Man
(n = 761)
Woman
(n = 771)
Age, y
Mean (SD) 28.75 (11.29) 28.95
(11.94)
31.36 (13.08) 32.06 (14.17) 30.40 (12.81)
Median (IQR) 26 (21-34) 25 (20-34) 27 (21-38) 30 (22-41) 26 (21-37)
≤24 59 (45.4) 357 (47.2) 308 (40.3) 170 (39.3) 894 (42.9)
25-44 57 (43.8) 311 (41.1) 330 (43.1) 184 (42.5) 882 (42.3)
45-64 13 (10.0) 81 (10.7) 111 (14.5) 71 (16.4) 276 (13.2)
≥65a NA NA NA NA 33 (1.6)
Abbreviation: IQR, interquartile range; NA, not
applicable.
a Denotes suppressed values because of small number
of participants in this category.
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Table 3. Comparative Health Service Use Between Transgender and Age-Matched Cisgender Individuals From January 2012 to December 2016
Transgender individuals
(n = 2085)
Cisgender individuals
(n = 10 425)
Total
(N = 12 510) P value SMD Variance ratio
Physician visits
Overall PCP visits
Mean (SD) 22.55 (27.15) 13.18 (19.62) 14.74 (21.35) .40 1.91 <.001
Median (IQR) 16 (8-28) 8 (3-17) 9 (4-19) .60 0.92 <.001
Sum 47 026 137 414 184 440 NA NA NA
MH PCP visits
Mean (SD) 9.11 (20.19) 2.10 (13.44) 3.27 (15.01) .41 2.26 <.001
Median (IQR) 4 (1-10) 0 (0-1) 0 (0-2) 1.33 1.12 <.001
Sum 19 000 21 897 40 897 NA NA NA
Non-MH PCP visits
Mean (SD) 13.44 (14.66) 11.08 (13.19) 11.47 (13.47) .17 1.24 <.001
Median (IQR) 9 (4-18) 8 (3-15) 8 (3-16) .22 0.93 <.001
Sum 28 026 115 517 143 543 NA NA NA
Total psychiatrist visits
Mean (SD) 8.25 (23.13) 0.93 (9.57) 2.15 (13.15) .41 5.84 <.001
Median (IQR) 1 (0-6) 0 (0-0) 0 (0-0) 1.23 3.26 <.001
Sum 17 210 9691 26 901 NA NA NA
Total urologist visits
Mean (SD) 0.29 (1.47) 0.13 (0.95) 0.16 (1.06) .13 2.37 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .17 1.88 <.001
Sum 605 1354 1959 NA NA NA
Total plastic surgeon visits
Mean (SD) 0.38 (1.16) 0.16 (0.90) 0.20 (0.95) .21 1.68 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .32 2.35 <.001
Sum 787 1698 2485 NA NA NA
Total OBGYN visits
Mean (SD) 0.66 (2.49) 1.21 (5.23) 1.12 (4.89) .13 0.23 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .02 0.98 0.482
Sum 1366 12 583 13 949 NA NA NA
Total cardiologist visits
Mean (SD) 0.18 (2.02) 0.12 (1.16) 0.13 (1.34) .04 3.06 0.06
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .08 1.39 <.001
Sum 366 1200 1566 NA NA NA
Total endocrinologist visits
Mean (SD) 0.92 (2.35) 0.13 (0.94) 0.26 (1.32) .44 6.21 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .57 5.23 <.001
Sum 1911 1325 3236 NA NA NA
Total ED visits
Overall visits
Mean (SD) 4.66 (11.05) 1.88 (3.95) 2.35 (5.86) .33 7.84 <.001
Median (IQR) 2 (0-5) 1 (0-2) 1 (0-3) .50 1.14 <.001
Sum 9717 19 621 29 338 NA NA NA
MH ED visits
Mean (SD) 1.22 (5.18) 0.11 (0.76) 0.30 (2.26) .30 46.28 <.001
Median (IQR) 0 (0-1) 0 (0-0) 0 (0-0) .69 4.2 <.001
Sum 2536 1174 3710 NA NA NA
SH ED visits
Mean (SD) 0.13 (0.91) 0.01 (0.36) 0.03 (0.50) .18 6.53 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .34 8.82 <.001
Sum 279 135 414 NA NA NA
(continued)
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vs 0.93 [9.57]; SMD, 5.84), and nonpsychiatric specialist visits (eg, endocrinologist visits: 0.92 [2.35]
vs 0.13 [0.94]; SMD, 6.21) compared with the general population. Total mean (SD) ED visits were
higher among transgender individuals (4.66 [11.05] vs 1.88 [3.95]; SMD, 7.84), particularly for mental
health (1.22 [5.18] vs 0.11 [0.76]; SMD, 46.28) and self-harm (0.13 [0.91] vs 0.01 [0.36]; SMD, 6.53)
compared with the matched controls. Transgender individuals also had higher mean (SD) rates of
hospitalization compared with the general population (0.77 [2.25] vs 0.23 [0.77]; SMD, 8.41),
especially for mental health–related reasons (0.53 [1.87] vs 0.03 [0.33]; SMD, 31.4).
eTable 2 in the Supplement presents health service use among transgender individuals by
gender identity category. Overall health service use was similar among all groups of transgender
individuals. Total mean (SD) mental health–related primary care physician visits were numerically
higher among transgender women compared with the overall transgender sample (10.11 [23.16] vs
9.11 [20.19]; P = .41), whereas non–mental health–related primary care physician visits were slightly
numerically higher among transgender men compared with the overall transgender sample (14.57
[16.72] vs 13.44 [14.66]; P = .17), but neither difference was statistically significance. There were
minimal differences for specialist visits, ED visits, and hospitalizations among the
transgender sample.
Discussion
We found that transgender individuals were more likely to live in lower-income neighborhoods,
experience chronic physical andmental health conditions, and have higher health service use
compared with the general population. Specifically, our study found higher rates of asthma, COPD,
diabetes, and HIV and greater rates of mental health comorbidity. Transgender individuals were
much more likely to see their primary care physician, visit the ED, and be admitted to the hospital,
particularly for mental health and self-harm–related reasons, compared with the general population.
Transgender individuals frequently face discrimination, stigma, violence, and barriers to
housing, employment, and education.1,22 A 2019 US study23 reported that transgender individuals
have especially high rates of poverty (29.4%) compared with cisgender individuals (15.7%), which is
further affected by racial and sexual orientationminority statuses. Our results show a similar trend,
Table 3. Comparative Health Service Use Between Transgender and Age-Matched Cisgender Individuals From January 2012 to December 2016 (continued)
Transgender individuals
(n = 2085)
Cisgender individuals
(n = 10 425)
Total
(N = 12 510) P value SMD Variance ratio
Non-MH ED visits
Mean (SD) 3.31 (6.67) 1.76 (3.49) 2.02 (4.23) .29 3.66 <.001
Median (IQR) 1 (0-4) 1 (0-2) 1 (0-2) .36 1.12 <.001
Sum 6902 18 312 25 214 NA NA NA
Total No. of hospitalizations
Overall hospitalizations
Mean (SD) 0.77 (2.25) 0.23 (0.77) 0.32 (1.18) .32 8.41 <.001
Median (IQR) 0 (0-1) 0 (0-0) 0 (0-0) .39 1.84 <.001
Sum 1602 2366 3968 NA NA NA
MH hospitalizations
Mean (SD) 0.53 (1.87) 0.03 (0.33) 0.12 (0.84) .37 31.4 <.001
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .60 8.64 <.001
Sum 1105 357 1462 NA NA NA
Non-MH hospitalizations
Mean (SD) 0.24 (1.11) 0.19 (0.67) 0.20 (0.76) .05 2.81 0.012
Median (IQR) 0 (0-0) 0 (0-0) 0 (0-0) .03 1.06 0.216
Sum 497 2009 2506 NA NA NA
Abbreviations: ED, emergency department; IQR, interquartile range; MH, mental health; OBGYN, obstetrician-gynecologist; PCP, Primary Care Provider; SH, self-harm; SMD,
standardizedmean difference.
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including potential barriers experienced by transgender individuals, such as a higher proportion of
them receiving public drug coverage (a marker of low income, as public drug coverage is based on
financial need) and living in lower-income neighborhoods compared with the general population.
This disparity can also increasingly contribute to the adverse health circumstances and high rates of
suicide experienced by transgender individuals. A 2015 survey-based study24 investigating the health
and well-being of 433 transgender individuals in Ontario reported that 77% of transgender
individuals had seriously considered suicide and 43% had attempted suicide.
Similar to our findings, previous studies have reported that transgender individuals experience
a wide range of health disparities and poor health outcomes compared with their cisgender
counterparts.2,4,9,25,26 For example, Proctor et al27 identified transgender Medicare beneficiaries in
the US by using a variety of claims information, including hormone prescriptions and gender identity
disorder diagnosis codes, and found that transgender individuals experienced high rates of
depression, anxiety disorders, posttraumatic stress disorder, schizophrenia, and other psychotic
disorders. Transgender individuals experience major challenges accessing health care because of a
lack of transgender-competent and inclusive health services, lack of practitioners with sufficient
transgender inclusion training, and systemic discrimination in primary health services and
hospitals.3,10,28
An Ontario-based study14 found that 21% of transgender individuals reported avoiding the ED
when they needed it because of previous stigma and discrimination based on their gender identity.
While previous research has indicated that transgender individuals may avoid health services,29-31
our study shows transgender individuals use health services at much higher rates than the general
population. We assessed transgender individuals who were attached to primary care, some of whom
may have been actively medically transitioning either through transition-related surgery and/or
hormone therapy, whichmay explain primary care physician visits. However, the high rates of ED
visits are worrisome in the context of primary care physician attachment, especially given that all
participating clinics specialized in transgender health. The higher rates of health service use for
mental health and self-harm–related reasons may reflect the health service manifestation of stigma
and discrimination.
The transgender sample identified in our study was relatively young, consistent with previous
research, which has reported that transgender individuals are more likely to be younger compared
with the overall population.32,33 Future efforts should be made to improve identification of older
transgender individuals. Future studies should also investigate the health service use and health
outcomes among transgender individuals living in small town and rural settings. Additionally, future
research should examine howmedical transition status (hormones and/or transition-related surgery)
affects mental health outcomes and health service use, particularly mental health and self-harm–
related ED visits and hospitalizations.
Strengths and Limitations
Amajor strength of our study is the large sample of transgender individuals we were able to identify
and link to administrative data. The size of our sample allowed us to assess the sociodemographic
characteristics, chronic health conditions, and health service use of transgender individuals
compared with the general population as well as compare these characteristics with data on health
service use among gender identity categories, an area that has not been previously assessed.
Our study has several limitations. The participating health clinics were located in larger cities
across Ontario, resulting in a sample of transgender individuals mainly located in urban settings, with
minimal representation of transgender individuals living in small town and rural settings. We are
unable to ascertain the degree to which our sample, based on the 4 clinics, is representative of the
regional distribution of transgender individuals in Ontario. This may have limited the generalizability
of the findings. Even though the transgender sample comprised individuals who self-identified as
transgender, there is a chance that transgender individuals were included in the comparison sample,
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because we did not identify all of the transgender people in Ontario. Additionally, the Ontario Drug
Benefit Database only included individuals who filled an outpatient drug prescription.
Conclusions
This study found that transgender individuals tend to live in lower-income neighborhoods and
experience higher rates of chronic conditions, including HIV, diabetes, asthma, COPD, andmental
health comorbidities, compared with the general population. We also found that transgender
individuals have significantly higher rates of health service use, particularly formental health and self-
harm–related reasons, even though they were connected to a primary care clinic specializing in
transgender health.
Our study highlights the need to better understand the factors underlying the health disparities
and high rates of mental health comorbidities experienced by transgender individuals. It
demonstrates the importance of collecting gender identity information and the need for health care
professionals to be attuned to the high potential for mental health issues and self-harm among
transgender individuals. Efforts to improve the capacity to identify transgender individuals in
administrative health care data would help to understand their health needs and inform public health
and health service interventions to reduce the high rates of disease burden.
ARTICLE INFORMATION
Accepted for Publication: June 16, 2020.
Published: August 28, 2020. doi:10.1001/jamanetworkopen.2020.15036
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Abramovich
A et al. JAMA Network Open.
Corresponding Author: Alex Abramovich, PhD, Institute for Mental Health Policy Research, Centre for Addiction
andMental Health, 33 Russell St, Toronto, ONM5S 2S1, Canada (alex.abramovich@camh.ca).
Author Affiliations: Institute for Mental Health Policy Research, Centre for Addiction andMental Health, Toronto,
Ontario, Canada (Abramovich, deOliveira, Iwajomo, Ross, Kurdyak); Dalla Lana School of Public Health, University
of Toronto, Toronto, Ontario, Canada (Abramovich, Ross); ICES, Toronto, Ontario, Canada (de Oliveira, Kiran,
Iwajomo, Kurdyak); Centre for Health Economics and Hull York Medical School, University of York, Heslington,
York, United Kingdom (de Oliveira); Institute of Health Policy, Management, and Evaluation, University of Toronto,
Toronto, Ontario, Canada (de Oliveira, Kiran, Kurdyak); MAP Centre for Urban Health Solutions, Department of
Family and Community Medicine, St Michael’s Hospital, Toronto, Ontario, Canada (Kiran); Department of Family
and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada (Kiran); Quality
Business Unit, Ontario Health, Toronto, Ontario, Canada (Kiran); Department of Psychiatry, Faculty of Medicine,
University of Toronto, Toronto, Ontario, Canada (Ross, Kurdyak).
Author Contributions: For privacy reasons, the research analyst was the only teammember who had full access
to all the data in the study. Ms Iwajomo had full access to all of the data in the study and takes responsibility for the
integrity of the data and the accuracy of the data analysis. Dr Abramovich had final responsibility for the decision
to submit for publication.
Concept and design: Abramovich, de Oliveira, Ross, Kurdyak.
Acquisition, analysis, or interpretation of data: Abramovich, de Oliveira, Kiran, Iwajomo, Kurdyak.
Drafting of the manuscript: Abramovich.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: de Oliveira, Iwajomo, Kurdyak.
Obtained funding: Abramovich, Kurdyak.
Administrative, technical, or material support: Abramovich, de Oliveira.
Supervision: de Oliveira, Kurdyak.
Conflict of Interest Disclosures:None reported.
JAMANetworkOpen | Public Health Health Conditions and Health Service Use Among Transgender Patients in Canada
JAMA Network Open. 2020;3(8):e2015036. doi:10.1001/jamanetworkopen.2020.15036 (Reprinted) August 28, 2020 10/12
Downloaded From: https://jamanetwork.com/ on 09/10/2020
Funding/Support: This study was funded by the Centre for Addiction andMental Health Discovery Fund. This
study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-
term Care.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection,
management, analysis, and interpretation of the data; preparation, review, or approval of themanuscript; and
decision to submit themanuscript for publication.
Disclaimer:No endorsement by ICES or the Ontario Ministry of Health and Long-term Care is intended or should
be inferred. Parts of this material are based on data and information compiled and provided by the Canadian
Institute for Health Information. However, the analyses, conclusions, opinions and statements expressed herein
are solely those of the author(s) and do not reflect those of the institute or the funding sources.
REFERENCES
1. Winter S, DiamondM, Green J, et al. Transgender people: health at themargins of society. Lancet. 2016;388
(10042):390-400. doi:10.1016/S0140-6736(16)00683-8
2. Giblon R, Bauer GR. Health care availability, quality, and unmet need: a comparison of transgender and
cisgender residents of Ontario, Canada. BMC Health Serv Res. 2017;17(1):283. doi:10.1186/s12913-017-2226-z
3. Grant JM, Motter LA, Tanis J. Injustice at Every Turn: A Report of the National Transgender Discrimination
Survey. National Center for Transgender Equality and National Gay and Lesbian Task Force; 2011.
4. Reisner SL, Poteat T, Keatley J, et al. Global health burden and needs of transgender populations: a review.
Lancet. 2016;388(10042):412-436. doi:10.1016/S0140-6736(16)00684-X
5. Abramovich A, Lam JSH, Chowdhury M. A transgender refugee woman experiencing posttraumatic stress
disorder symptoms and homelessness. CMAJ. 2020;192(1):E9-E11. doi:10.1503/cmaj.190974
6. Bauer GR, Hammond R, Travers R, KaayM, Hohenadel KM, BoyceM. “I don’t think this is theoretical; this is our
lives”: how erasure impacts health care for transgender people. J Assoc Nurses AIDS Care. 2009;20(5):348-361.
doi:10.1016/j.jana.2009.07.004
7. BocktingWO, Miner MH, Swinburne Romine RE, Hamilton A, Coleman E. Stigma, mental health, and resilience
in an online sample of the US transgender population. Am J Public Health. 2013;103(5):943-951. doi:10.2105/
AJPH.2013.301241
8. Bradford J, Reisner SL, Honnold JA, Xavier J. Experiences of transgender-related discrimination and
implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2013;103
(10):1820-1829. doi:10.2105/AJPH.2012.300796
9. Clark TC, LucassenMFG, Bullen P, et al. The health and well-being of transgender high school students: results
from the New Zealand adolescent health survey (Youth’12). J Adolesc Health. 2014;55(1):93-99. doi:10.1016/j.
jadohealth.2013.11.008
10. Riggs DW, Coleman K, Due C. Healthcare experiences of gender diverse Australians: a mixed-methods, self-
report survey. BMC Public Health. 2014;14:230. doi:10.1186/1471-2458-14-230
11. Veale J, Saewyc E, Frohard-Dourlent H, Dobson S, Clark B. Being Safe, Being Me: Results of the Canadian Trans
Youth Health Survey. School of Nursing and University of British Columbia; 2016.
12. Eyssel J, Koehler A, Dekker A, Sehner S, Nieder TO. Needs and concerns of transgender individuals regarding
interdisciplinary transgender healthcare: a non-clinical online survey. PLoS One. 2017;12(8):e0183014. doi:10.1371/
journal.pone.0183014
13. Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying patients with physician-
diagnosed asthma in health administrative databases. Can Respir J. 2009;16(6):183-188. doi:10.1155/2009/
963098
14. Bauer GR, Scheim AI, DeutschMB, Massarella C. Reported emergency department avoidance, use, and
experiences of transgender persons in Ontario, Canada: results from a respondent-driven sampling survey. Ann
Emerg Med. 2014;63(6):713-20.e1. doi:10.1016/j.annemergmed.2013.09.027
15. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a
validated administrative data algorithm. Diabetes Care. 2002;25(3):512-516. doi:10.2337/diacare.25.3.512
16. Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures
and onmortality after acute myocardial infarction. N Engl J Med. 1999;341(18):1359-1367. doi:10.1056/
NEJM199910283411806
17. Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian
diagnosed COPD in health administrative databases. COPD. 2009;6(5):388-394. doi:10.1080/
15412550903140865
JAMANetworkOpen | Public Health Health Conditions and Health Service Use Among Transgender Patients in Canada
JAMA Network Open. 2020;3(8):e2015036. doi:10.1001/jamanetworkopen.2020.15036 (Reprinted) August 28, 2020 11/12
Downloaded From: https://jamanetwork.com/ on 09/10/2020
18. Schultz SE, Rothwell DM, Chen Z, Tu K. Identifying cases of congestive heart failure from administrative data:
a validation study using primary care patient records. Chronic Dis Inj Can. 2013;33(3):160-166.
19. Steele LS, Glazier RH, Lin E, Evans M. Using administrative data to measure ambulatory mental health service
provision in primary care.Med Care. 2004;42(10):960-965. doi:10.1097/00005650-200410000-00004
20. Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA. Accuracy of administrative databases in
identifying patients with hypertension.OpenMed. 2007;1(1):e18-e26.
21. Weiner J. The Johns Hopkins ACG Case-Mix System Version 6.0 Release Notes. Johns Hopkins University
Bloomberg School of Public Health; 2003.
22. Shelton J, WagamanMA, Small L, Abramovich A. I’mmore driven now: resilience and resistance among
transgender and gender expansive youth and young adults experiencing homelessness. Int J Transgenderism.
2018;19(2):144-157. doi:10.1080/15532739.2017.1374226
23. Badgett L, Choi SK, Wilson B. LGBT Poverty in the United States: A Study of Differences Between Sexual
Orientation and Gender Identity Groups. UCLA School of Law,Williams Institute; 2019.
24. Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R. Intervenable factors associated with suicide risk in
transgender persons: a respondent driven sampling study in Ontario, Canada. BMC Public Health. 2015;15:
525-525. doi:10.1186/s12889-015-1867-2
25. Connolly MD, Zervos MJ, Barone CJ II, Johnson CC, Joseph CL. Themental health of transgender youth:
advances in understanding. J Adolesc Health. 2016;59(5):489-495. doi:10.1016/j.jadohealth.2016.06.012
26. Schuster MA, Reisner SL, Onorato SE. Beyond bathrooms—meeting the health needs of transgender people.
N Engl J Med. 2016;375(2):101-103. doi:10.1056/NEJMp1605912
27. Proctor K, Haffer SC, Ewald E, Hodge C, James CV. Identifying the transgender population in theMedicare
program. Transgend Health. 2016;1(1):250-265. doi:10.1089/trgh.2016.0031
28. Shires DA, Jaffee K. Factors associated with health care discrimination experiences among a national sample
of female-to-male transgender individuals.Health SocWork. 2015;40(2):134-141. doi:10.1093/hsw/hlv025
29. Safer JD, Coleman E, Feldman J, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol
Diabetes Obes. 2016;23(2):168-171. doi:10.1097/MED.0000000000000227
30. Vermeir E, Jackson LA,Marshall EG. Barriers to primary and emergency healthcare for trans adults. Cult Health
Sex. 2018;20(2):232-246. doi:10.1080/13691058.2017.1338757
31. White Hughto JM, Murchison GR, Clark K, Pachankis JE, Reisner SL. Geographic and individual differences in
healthcare access for US transgender adults: a multilevel analysis. LGBT Health. 2016;3(6):424-433. doi:10.1089/
lgbt.2016.0044
32. Dragon CN, Guerino P, Ewald E, Laffan AM. Transgender Medicare beneficiaries and chronic conditions:
exploring fee-for-service claims data. LGBT Health. 2017;4(6):404-411. doi:10.1089/lgbt.2016.0208
33. Herman JL, Flores AR, Brown TN,Wilson BD, Conron KJ. Age of Individuals Who Identify as Transgender in the
United States. TheWilliams Institute; 2017.
SUPPLEMENT.
eTable 1. Comparative Health Service Use Between Transgender and Age-Matched Cisgender Individuals From
2012 to 2016
eTable 2.Health Service Use of Transgender Individuals by Gender Identity Category From 2012 to 2016
eAppendix 1. Self-Reported Gender Identities
eAppendix 2. ACGs and ADGs Information
JAMANetworkOpen | Public Health Health Conditions and Health Service Use Among Transgender Patients in Canada
JAMA Network Open. 2020;3(8):e2015036. doi:10.1001/jamanetworkopen.2020.15036 (Reprinted) August 28, 2020 12/12
Downloaded From: https://jamanetwork.com/ on 09/10/2020
